Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1AMERICAN JOURNAL OF TRANSPLANTATIONIF8.22024-11-011OA
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsSCIENCE TRANSLATIONAL MEDICINEIF14.62023-02-0115PRE
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversificationCELL REPORTSIF6.92022-03-014OA
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesMOLECULAR CANCER THERAPEUTICSIF5.52020-10-025OAAI
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophyPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12017-11-0686OAAI
Exploring host-pathogen interactions through genome wide protein microarray analysisSCIENTIFIC REPORTSIF3.92016-06-1521OAAI